Literature DB >> 14624488

Persistence of graded EphA/Ephrin-A expression in the adult frog visual system.

Helene Bach1, David A Feldheim, John G Flanagan, Frank Scalia.   

Abstract

Many studies have demonstrated the involvement of the EphA family of receptor tyrosine kinases and their ligands, ephrin-A2 and -A5, in the development of the temporonasal axis of the retinotectal/collicular map, but the role of these molecules in optic nerve regeneration has not been well studied. Noting that the characteristic gradients of the EphA/ephrin-A family that are expressed topographically in the retina and tectum of embryonic chicks and mice tend to disappear after birth, we took as our starting point an analysis of EphA and ephrin-A expression in leopard frogs (Rana pipiens and utricularia), species capable of regenerating the retinotectal map as adults. For the EphA family to be involved in the regeneration, one would expect these topographic gradients to persist in the adult or, if downregulated after metamorphosis, to be reexpressed after optic nerve injury. Using EphA3 receptor and ephrin-A5 ligand alkaline phosphatase in situ affinity probes (RAP and LAP, respectively) in whole-mount applications, we report that reciprocally complementary gradients of RAP and LAP binding persist in the optic tract and optic tectum of postmetamorphic frogs, including mature adults. EphA expression in temporal retinal axons in the optic tract was significantly reduced after nerve section but returned during regeneration. However, ephrin-A expression in the tectal parenchyma was not significantly elevated by either eye removal, with degeneration of optic axons, or during regeneration of the retinotectal projection. Thus, the present study has demonstrated a persisting expression of EphA/ephrin-A family members in the retinal axons and tectal parenchyma that may help guide regenerating fibers, but we can offer no evidence for an upregulation of ephrin-A expression in conjunction with optic nerve injury. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624488     DOI: 10.1002/cne.10941

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  7 in total

Review 1.  Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury?

Authors:  Noam Y Harel; Stephen M Strittmatter
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

2.  Expression patterns of Ephs and ephrins throughout retinotectal development in Xenopus laevis.

Authors:  Valerie Higenell; Sang Myung Han; David A Feldheim; Frank Scalia; Edward S Ruthazer
Journal:  Dev Neurobiol       Date:  2012-04       Impact factor: 3.964

3.  Intrinsic positional memory guides target-specific axon regeneration in the zebrafish vagus nerve.

Authors:  Adam J Isabella; Jason A Stonick; Julien Dubrulle; Cecilia B Moens
Journal:  Development       Date:  2021-09-14       Impact factor: 6.862

Review 4.  Molecular complexity of visual mapping: a challenge for regenerating therapy.

Authors:  Mara Medori; Gonzalo Spelzini; Gabriel Scicolone
Journal:  Neural Regen Res       Date:  2020-03       Impact factor: 5.135

5.  Gradients of Eph-A6 expression in primate retina suggest roles in both vascular and axon guidance.

Authors:  Peter Kozulin; Riccardo Natoli; Michele C Madigan; Keely M Bumsted O'Brien; Jan M Provis
Journal:  Mol Vis       Date:  2009-12-09       Impact factor: 2.367

6.  Caenorhabditis elegans neuronal regeneration is influenced by life stage, ephrin signaling, and synaptic branching.

Authors:  Zilu Wu; Anindya Ghosh-Roy; Mehmet Fatih Yanik; Jin Z Zhang; Yishi Jin; Andrew D Chisholm
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

7.  Complementary expression of EphA7 and SCO-spondin during posterior commissure development.

Authors:  Karen Stanic; América Vera; Melissa González; Antonia Recabal; Allison Astuya; Marcela Torrejón; Hernán Montecinos; Teresa Caprile
Journal:  Front Neuroanat       Date:  2014-06-24       Impact factor: 3.856

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.